Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease

Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease

Abstract Introduction Routine defibrillation threshold (DFT) testing at the time of implantable cardioverter-defibrillator (ICD) implantation is no longer recommended because testing did not improve shock efficacy or reduce arrhythmic death. However, patients with severe chronic kidney disease (CKD)...

Full description

Saved in:
Bibliographic Details
Main Authors: Rohit J. Timal, Lano Osman, Joris I. Rotmans, Marianne Bootsma, Bart Mertens, Martin J. Schalij, Ton J. Rabelink, J. Wouter Jukema
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Cardiology and Therapy
Subjects:
Implantable cardioverter-defibrillator
End-stage kidney disease
Chronic kidney disease
Dialysis
Defibrillation threshold testing
Defibrillation efficacy testing
Online Access:https://doi.org/10.1007/s40119-025-00403-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40119-025-00403-x

Similar Items